Hereditary ATTR Amyloidosis Archives

3dman_eu / Pixabay

Intellia Authorized to Begin NTLA-2001 Trial for hATTR

Post author:Jessica Lynn
Post published:October 28, 2020
Post category:Hereditary ATTR Amyloidosis Rare Disease

In a recent press release, genome editing company Intellia Therapeutics, Inc. ("Intellia") announced its recent MHRA authorization to begin a Phase 1 clinical trial to evaluate its therapeutic candidate NTLA-2001. The…

source: pixabay.com

Four Doctors Who Worked on the Development of Tafamidis Criticize its Price

Post author:Rose Duesterwald
Post published:December 10, 2019
Post category:Hereditary ATTR Amyloidosis

A recent article in Bloomberg’s SFGate focused on the price of drugs. The average patient cannot afford the price of many drugs now on the market. Insurance companies have…

https://pixabay.com/en/seattle-city-urban-cityscape-870282/

You Can Help Raise Money for Amyloidosis Research This October

Post author:Jessica Gladwell
Post published:September 27, 2017
Post category:Amyloidosis Hereditary ATTR Amyloidosis Rare Disease

PW Partner the Amyloidosis Foundation (AF) is hosting their annual amyloidosis research benefit and you won't want to miss it! The AF was founded by two amazing amyloidosis patients who strived…

Intellia Authorized to Begin NTLA-2001 Trial for hATTR

Four Doctors Who Worked on the Development of Tafamidis Criticize its Price

You Can Help Raise Money for Amyloidosis Research This October

Make a difference, share your experiences and get paid. Opt-in & join Patient Worthy’s panel for paid opportunities such as Surveys, Market Research, Patient Advisory Panels & much more.

Let’s Work Together!

Keep Up to Date

Learn More

SIGN UP FOR OUR NEWSLETTER
Email Address